QLT's mission has remained constant over the years: to improve people's lives while creating shareholder value. We intend to work creatively and productively to make the best use of our assets and resources to achieve that goal.
We are focused on our future as we continue to build, strengthen and grow the company. We plan to advance our best programs in clinical trials, and ultimately seek regulatory approval, and look for new products that will build on our pipeline.
We plan to build an ocular pipeline focused on innovative therapies that can preserve or improve vision.
Build
- Build an ocular pipeline
- Deliver near-term growth
- Build sustainable long-term growth
|
Strengthen
- Solidify a commercial presence in ocular
|
Compounding Growth
- Maximize the revenue from our product sales of Visudyne®
- Identify potential in-licensing candidates and acquisitions targets opportunistically
|
Bob Butchofsky
President and CEO | 
